Americas

Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s interests by going back and forth among concurrent tracks.

DPHARM is designed for drug development innovative thinkers who are determined to re-invent clinical trials. Going into its fifteenth year, the conference explores how clinical trials can be reimagined to be more efficient, more patient-focused, more accurate, quicker and less costly.  The conference has become highly regarded among executives at Pharma companies, Biotechs and CROs.

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forwardthinking approaches for implementing digital technology to improve clinical trials.

DIA has been the world’s leading member-based, non-profit organization driving innovation in patient safety and outcomes. We attract thousands of leading international life sciences organizations from Pharma, Biotech, Medical Device, and Diagnostic Equipment together with global regulatory agencies and leading academic researchers in a neutral, collaborative environment.

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

Our unparalleled annual gathering of the leading innovators, investors, payers, providers and policymakers who are driving the digital health revolution.

Join other leading innovators, investors, payers, providers, and policymakers as we continue to help revolutionize healthcare by discussing the most pertinent topics to the field.

BIO attracts leading biotechs, top 25 pharma, top 20 CROs and CMOs and major research labs and government agencies. The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. The conference brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.

Baird is delighted to host its annual Global Healthcare Conference. This conference brings institutional and private equity investors together with senior management from over 90 public and privately-held companies. The conference will feature companies across the following sectors: Biotechnology, Healthcare Supply Chain & Pharma Services, Healthcare Information Technology, Life Sciences & Diagnostics, Medical Technology and Facilities & Services. 

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.